Skip to content

a clinical trial to study the effect of emdogain (enamel matrix derivative) material on fixation of implant to bone, gum health, bone level

Comparative Evaluation Of Implant Stability, Gingival Soft Tissue And Marginal Bone Level In Emdogain Treated And Conventional Implants :Randomized Controlled Clinical Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069247
Enrollment
15
Registered
2024-06-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K081- Complete loss of teeth

Interventions

Intervention1: emdogain treated implant: emdogain is an enamel matrix derivative with amelogenin as main component and it comes in a syringe form and directly applied on the surface of implant before

Sponsors

Dr Mitali Niras
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 age above 18 years 2 Able to provide consent 3 Patient needs implants in 2 areas in the same arch

Exclusion criteria

Exclusion criteria: 1 Patients with medical history in which any dental intervention would be contraindicated 2 Patients with any local or systemic disease condition or medication that might compromise health of the periodontium 3 Pregnant and lactating women 4 Current chemotherapy radiotherapy or drugs that interfere with study 5 Patients who are not willing to sign the consent form

Design outcomes

Primary

MeasureTime frame
Implant stability and Gingival soft tissue and Marginal bone levelTimepoint: Implant stability at baseline 3 months, 6 months and 12 months gingival soft tissue and marginal bone level at 3 months, 6 months and 12 months

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Mitali Niras

K M Shah dental college and hospital

drtamannachhabra@gmail.com8758868392

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026